News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
506,637 Results
Type
Article (9439)
Company Profile (144)
Press Release (500861)
Multimedia
Podcasts (4)
Webinars (6)
Section
Business (172805)
Career Advice (349)
Deals (26602)
Drug Delivery (15)
Drug Development (55771)
Employer Resources (20)
FDA (10531)
Job Trends (9018)
News (248559)
Policy (19041)
Tag
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (3)
2027 Genetown Elite (1)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (2)
Academia (571)
Accelerated approval (22)
ADA (18)
Adcomms (1)
Allergies (107)
Alliances (34810)
ALS (108)
Alzheimer's disease (1015)
Antibody-drug conjugate (ADC) (265)
Approvals (10979)
Artificial intelligence (338)
ASCO (172)
Autoimmune disease (201)
Automation (30)
Bankruptcy (264)
Best Places to Work (7274)
BIO (40)
BIOSECURE Act (1)
Biosimilars (113)
Biotechnology (93)
Bladder cancer (144)
Brain cancer (31)
Breast cancer (528)
Cancer (3765)
Cardiovascular disease (223)
Career advice (266)
Career pathing (2)
CAR-T (175)
CDC (1)
Celiac Disease (1)
Cell therapy (490)
Cervical cancer (35)
Clinical research (49993)
Collaboration (1293)
Commercialization (1)
Compensation (1394)
Complete response letters (33)
COVID-19 (825)
CRISPR (65)
C-suite (735)
Cystic fibrosis (84)
Data (5822)
Denatured (4)
Depression (101)
Dermatology (61)
Diabetes (359)
Diagnostics (4483)
Digital health (38)
Diversity (2)
Diversity, equity & inclusion (7)
Drug discovery (156)
Drug pricing (18)
Drug shortages (2)
Duchenne muscular dystrophy (185)
Earnings (74357)
Editorial (1)
Employer branding (2)
Employer resources (17)
Events (90870)
Executive appointments (701)
FDA (13044)
Fibrodysplasia Ossificans Progressiva (8)
Friedreich's ataxia (17)
Frontotemporal dementia (26)
Funding (939)
Gene editing (126)
Generative AI (12)
Gene therapy (328)
GLP-1 (351)
Government (1069)
Grass and pollen (2)
Guidances (292)
Healthcare (9933)
Hematology (100)
HIV (55)
Huntington's disease (22)
IgA nephropathy (62)
Immunology and inflammation (101)
Immuno-oncology (55)
Indications (158)
Infectious disease (1025)
Inflammatory bowel disease (135)
Inflation Reduction Act (5)
Influenza (91)
Intellectual property (259)
Interviews (43)
IPO (12731)
IRA (2)
Job creations (2035)
Job search strategy (253)
JPM (2)
Kidney cancer (16)
Layoffs (61)
Leadership (1)
Legal (5305)
Liver cancer (46)
Longevity (17)
Lung cancer (514)
Lymphoma (268)
Machine learning (30)
Management (3)
Manufacturing (556)
Marketing (7)
MASH (120)
Medical device (9227)
Medtech (9354)
Mergers & acquisitions (14812)
Metabolic disorders (748)
mRNA (54)
Multiple sclerosis (104)
NASH (4)
Neurodegenerative disease (232)
Neuropsychiatric disorders (39)
Neuroscience (1892)
NextGen: Class of 2026 (3323)
Non-profit (978)
Obesity (247)
Opinion (16)
Ovarian cancer (156)
Pain (179)
Pancreatic cancer (202)
Parkinson's disease (216)
Partnered (12)
Patents (479)
Patient recruitment (503)
Peanut (36)
People (42626)
Pharmaceutical (31)
Pharmacy benefit managers (9)
Phase 1 (16075)
Phase 2 (22361)
Phase 3 (15083)
Pipeline (7008)
Policy (24)
Postmarket research (1634)
Preclinical (6786)
Press Release (49)
Prostate cancer (199)
Psychedelics (8)
Radiopharmaceuticals (198)
Rare diseases (577)
Real estate (3268)
Recruiting (6)
Regulatory (15542)
Reports (19)
Research institute (665)
Resumes & cover letters (50)
Rett syndrome (40)
RNA editing (6)
RSV (48)
Schizophrenia (113)
Series A (154)
Series B (129)
Service/supplier (4)
Sickle cell disease (63)
Spinal muscular atrophy (90)
Sponsored (8)
Startups (2104)
Stomach cancer (3)
Supply chain (51)
Vaccines (332)
Venture capital (17)
Weight loss (93)
Women's health (76)
Date
Today (9)
Last 7 days (265)
Last 30 days (1093)
Last 365 days (19938)
2026 (11231)
2025 (20196)
2024 (24034)
2023 (27838)
2022 (36448)
2021 (39328)
2020 (35815)
2019 (25196)
2018 (18910)
2017 (20205)
2016 (19285)
2015 (25859)
2014 (22666)
2013 (19074)
2012 (21220)
2011 (21346)
2010 (21070)
Location
Africa (267)
Alabama (71)
Alaska (4)
Arizona (294)
Arkansas (12)
Asia (20452)
Australia (3317)
California (11687)
Canada (3112)
China (574)
Colorado (477)
Connecticut (404)
Delaware (231)
Europe (34390)
Florida (1737)
Georgia (383)
Hawaii (2)
Idaho (48)
Illinois (722)
India (57)
Indiana (400)
Iowa (17)
Japan (411)
Kansas (103)
Kentucky (31)
Louisiana (24)
Maine (26)
Maryland (1178)
Massachusetts (7824)
Michigan (302)
Minnesota (575)
Mississippi (4)
Missouri (83)
Montana (25)
Nebraska (11)
Nevada (113)
New Hampshire (60)
New Jersey (2740)
New Mexico (20)
New York (2785)
North Carolina (1259)
North Dakota (4)
Northern California (5845)
Ohio (277)
Oklahoma (15)
Oregon (16)
Pennsylvania (2233)
Puerto Rico (22)
Rhode Island (30)
South America (444)
South Carolina (75)
South Dakota (1)
Southern California (4827)
Tennessee (121)
Texas (1884)
United States (38617)
Utah (347)
Vermont (1)
Virginia (157)
Washington D.C. (40)
Washington State (912)
West Virginia (1)
Wisconsin (88)
Wyoming (1)
506,637 Results for "seegene usa inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Seegene USA Receives FDA Emergency Use Authorization for Multiplex PCR Assay, Advancing Differential Diagnosis of HSV-1&2, VZV, and Monkeypox Virus for Ulcerative Skin Lesions
July 22, 2026
·
5 min read
Press Releases
Seegene Launches Industry’s First Global Million Clinical Study to Shape New Disease-Specific Testing Standards
July 8, 2026
·
3 min read
Press Releases
Seegene Introduces STAgora at ESCMID Global 2026, Highlighting Real-Time Data with Automated PCR Workflows
April 20, 2026
·
5 min read
Press Releases
Seegene Establishes French Subsidiary to Expand European Footprint
December 8, 2025
·
2 min read
Press Releases
Takara Bio USA, Inc. Announces the Retirement of Carol Lou, Appoints Andrew Farmer as President and CEO
July 9, 2026
·
4 min read
Biotech Beach
Seegene Technologies, Inc. Announces Name Change to Seegene USA, Inc.Company expands presence and support in US market
Seegene Technologies, Inc. announced it will change names and begin doing business as Seegene USA, Inc. , effective Jan. 1, 2023.
January 6, 2023
·
1 min read
Press Releases
Alembic Therapeutics, LLC Announces Acquisition of NUVESSA® (metronidazole vaginal gel 1.3%) from Exeltis USA, Inc.
June 9, 2026
·
1 min read
Press Releases
Takara Bio USA, Inc. to Showcase Instrument-Free Approach to Spatial Biology at Human Cell Atlas 2026 Meeting
June 16, 2026
·
4 min read
Microbix & Seegene USA Jointly Enhancing Lab Test Accuracy Expanded Collaboration to Improve Syndromic Infectious Disease Testing
Microbix Biosystems Inc., a life sciences innovator, manufacturer, and exporter, announces a collaboration with Seegene USA, Inc., a leading developer of multiplex molecular assays and automated solutions for U.S. labs.
December 14, 2023
·
5 min read
Press Releases
Takara Bio USA, Inc. Validates New Class of Spatial Technology with Benchmark Study for Cancer Research
April 20, 2026
·
3 min read
1 of 50,664
Next
